These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 17602205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Nanotechnology--possibilities and hazards].
    Snopczyński T, Góralczyk K, Czaja K, Struciński P, Hernik A, Korcz W, Ludwicki JK.
    Rocz Panstw Zakl Hig; 2009; 60(2):101-11. PubMed ID: 19803438
    [Abstract] [Full Text] [Related]

  • 6. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G.
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S, Hayes A, Dechsakulthorn F.
    Inhal Toxicol; 2012 Jan; 24(2):125-35. PubMed ID: 22260506
    [Abstract] [Full Text] [Related]

  • 9. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
    Simeonova PP, Erdely A.
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
    [Abstract] [Full Text] [Related]

  • 10. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management.
    Warheit DB, Reed KL, Sayes CM.
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():61-7. PubMed ID: 19558235
    [Abstract] [Full Text] [Related]

  • 11. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V, Kumari A, Guleria P, Yadav SK.
    Rev Environ Contam Toxicol; 2012 Jul; 215():39-121. PubMed ID: 22057930
    [Abstract] [Full Text] [Related]

  • 12. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management.
    Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM.
    Toxicol Lett; 2007 Jul 10; 171(3):99-110. PubMed ID: 17566673
    [Abstract] [Full Text] [Related]

  • 13. Nanotechnology and the occupational physician.
    Seaton A.
    Occup Med (Lond); 2006 Aug 10; 56(5):312-6. PubMed ID: 16868129
    [Abstract] [Full Text] [Related]

  • 14. Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials.
    Franco A, Hansen SF, Olsen SI, Butti L.
    Regul Toxicol Pharmacol; 2007 Jul 10; 48(2):171-83. PubMed ID: 17509740
    [Abstract] [Full Text] [Related]

  • 15. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC, Maynard AD.
    Risk Anal; 2010 Nov 10; 30(11):1634-44. PubMed ID: 20626687
    [Abstract] [Full Text] [Related]

  • 16. [Risks associated with nanotechnology based on European Union legislation].
    Hydzik P.
    Przegl Lek; 2012 Nov 10; 69(8):490-1. PubMed ID: 23243915
    [Abstract] [Full Text] [Related]

  • 17. Health effects of inhaled engineered and incidental nanoparticles.
    Madl AK, Pinkerton KE.
    Crit Rev Toxicol; 2009 Nov 10; 39(8):629-58. PubMed ID: 19743943
    [Abstract] [Full Text] [Related]

  • 18. Nanoparticle-induced pulmonary toxicity.
    Li JJ, Muralikrishnan S, Ng CT, Yung LY, Bay BH.
    Exp Biol Med (Maywood); 2010 Sep 10; 235(9):1025-33. PubMed ID: 20719818
    [Abstract] [Full Text] [Related]

  • 19. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD, Baumgartner L, Carr BM, Fish AM, Meyerhofer JD, Satterfield TA, Holden PA, Harthorn BH.
    J Occup Environ Hyg; 2013 Sep 10; 10(9):487-95. PubMed ID: 23927041
    [Abstract] [Full Text] [Related]

  • 20. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment.
    Bergamaschi E, Bussolati O, Magrini A, Bottini M, Migliore L, Bellucci S, Iavicoli I, Bergamaschi A.
    Int J Immunopathol Pharmacol; 2006 Sep 10; 19(4 Suppl):3-10. PubMed ID: 17291399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.